MX9706275A - El uso del alendronato para preparar composiciones para reducir el riesgo de fracturas vertebrales. - Google Patents

El uso del alendronato para preparar composiciones para reducir el riesgo de fracturas vertebrales.

Info

Publication number
MX9706275A
MX9706275A MX9706275A MX9706275A MX9706275A MX 9706275 A MX9706275 A MX 9706275A MX 9706275 A MX9706275 A MX 9706275A MX 9706275 A MX9706275 A MX 9706275A MX 9706275 A MX9706275 A MX 9706275A
Authority
MX
Mexico
Prior art keywords
lessening
risk
vertebral fractures
fractures
alendronate
Prior art date
Application number
MX9706275A
Other languages
English (en)
Other versions
MXPA97006275A (es
Inventor
David B Karpf
Thomas P Capizzi
Hui Quan
Arthur C Ii Santora
Ashley J Yates
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MX9706275A publication Critical patent/MX9706275A/es
Publication of MXPA97006275A publication Critical patent/MXPA97006275A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El alendronato, un bisfosfonato, cuando se administra diariamente durante un periodo substancial, puede reducir la tasa de fracturas vertebrales en mujeres post-menopausicas; además, puede reducir el numero y la severidad de las fracturas; asimismo, la administracion del alendronato puede prevenir la deformidad de la espina dorsal, y la pérdida de peso.
MXPA/A/1997/006275A 1995-02-17 1997-08-15 El uso del alendronato para preparar composiciones para reducir el riesgo de fracturas vertebrales MXPA97006275A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08389860 1995-02-17
US08/389,860 US20010051616A1 (en) 1995-02-17 1995-02-17 Method of lessening the risk of vertebral fractures
PCT/US1996/001946 WO1996025166A1 (en) 1995-02-17 1996-02-13 Method of lessening the risk of vertebral fractures

Publications (2)

Publication Number Publication Date
MX9706275A true MX9706275A (es) 1997-11-29
MXPA97006275A MXPA97006275A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
JPH11501906A (ja) 1999-02-16
AU689379B2 (en) 1998-03-26
EP0809503A1 (en) 1997-12-03
KR19980702209A (ko) 1998-07-15
CN1181008A (zh) 1998-05-06
PL321836A1 (en) 1997-12-22
EA000348B1 (ru) 1999-04-29
SK111697A3 (en) 1998-02-04
CA2213076A1 (en) 1996-08-22
EP0809503A4 (en) 2001-12-05
HUP9802077A3 (en) 2001-10-29
NZ303476A (en) 2000-07-28
HUP9802077A2 (hu) 2000-06-28
ZA961234B (en) 1996-08-27
EA199700185A1 (ru) 1997-12-30
AU4979996A (en) 1996-09-04
US20010051616A1 (en) 2001-12-13
WO1996025166A1 (en) 1996-08-22

Similar Documents

Publication Publication Date Title
PH30032A (en) Methods for inhibiting bone loss
ZA964816B (en) Implant for the surgical treatment of a vertebral isthmus fracture.
MY114265A (en) Alendronate therapy to prevent loosening of, or pain associated with orthopedic implant devices
AU1432795A (en) Devices and methods for posterior spinal fixation
MX9207349A (es) Metodos para el tratamiento de osteoporosis utilizando bisfosfonatos y hormona de paratiroides.
CA2262269A1 (en) Treatment of skeletal disorders
GB2228417B (en) Posterior spinal system and method
HK1021620A1 (en) Acending-dose dosage form
IL134564A0 (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
MX9707535A (es) Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario.
AU5482696A (en) Orthotic apparatus useful for treating pain associated with spinal disorders
EP0668750A4 (en) PEDICULAR SCREW AND INSTRUMENTS FOR REAR SPINE CORRECTION.
EP0599419A3 (en) Disk-shaped implant for reinforcing adjacent vertebrae.
EP0590745A3 (en) Spinal support system and method.
EP0748634A3 (de) Implantat, seine Verwendung in der Chirurgie und Verfahren zu seiner Herstellung
EP0746255A4 (en) CROSS-LINK FOR VERTEBRAL IMPLANT SYSTEM
PL309693A1 (en) Combined osteoporosis inhibiting treatment
GB9408775D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
NZ303022A (en) Treatment of osteoporotic diseases with alendronate
WO1999004772A3 (en) Use of levobupivacaine
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
HUT68171A (en) Preparations containing 4-aminopyridine for the treatment of neurological conditions
EA199700185A1 (ru) Способ уменьшения риска вертебральных переломов
MX9703944A (es) Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
AU3607293A (en) Implant therapy for bone growth stimulation